These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3522031)

  • 21. Routine prophylactic lidocaine in acute myocardial infarction.
    Barnaby PF; Barrett PA; Lvoff R
    Heart Lung; 1983 Jul; 12(4):362-6. PubMed ID: 6553038
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E
    Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials.
    MacMahon S; Collins R; Peto R; Koster RW; Yusuf S
    JAMA; 1988 Oct; 260(13):1910-6. PubMed ID: 3047448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lidocaine prophylaxis in acute myocardial infarction.
    Tisdale JE
    Henry Ford Hosp Med J; 1991; 39(3-4):217-25. PubMed ID: 1804827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction.
    Abraham AS; Rosenmann D; Kramer M; Balkin J; Zion MM; Farbstien H; Eylath U
    Arch Intern Med; 1987 Apr; 147(4):753-5. PubMed ID: 3548627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic lidocaine for postoperative coronary artery bypass patients, a double-blind, randomized trial.
    King FG; Addetia AM; Peters SD; Peachey GO
    Can J Anaesth; 1990 Apr; 37(3):363-8. PubMed ID: 2182208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic lignocaine in hospitalized patients with acute myocardial infarction.
    O'Brien KP; Taylor PM; Croxson RS
    Med J Aust; 1973 Aug; 2(1):Suppl:36-7. PubMed ID: 4598559
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.
    Valentine PA; Frew JL; Mashford ML; Sloman JG
    N Engl J Med; 1974 Dec; 291(25):1327-31. PubMed ID: 4610393
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
    Nieminen MS; Toivonen LK; Manninen V; Frick MH
    Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to medication on a coronary care unit.
    Falk RH
    Postgrad Med J; 1979 Dec; 55(654):870-3. PubMed ID: 44912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
    Wilcox RG; Eastgate J; Harrison E; Skene AM
    Br Heart J; 1991 Jan; 65(1):4-8. PubMed ID: 1899582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].
    Capucci A; Melandri G; Mantovani B; Maresta A; Magnani B
    G Ital Cardiol; 1985 Mar; 15(3):285-9. PubMed ID: 4018467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiarrhythmic action of lidocaine and its side effects].
    Fomina IG; Minushkin ON; Lidskiĭ PI; Sverchkova EI; Ternovaia AS
    Klin Med (Mosk); 1977 May; 55(5):64-70. PubMed ID: 875337
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative clinical study of trimecaine and lidocaine as anti-arrhythmia agents in myocardial infarct].
    Riabokon' OS; Piotrovskiĭ VK; Smirnova EB; Metelitsa VI; Mazur NA
    Kardiologiia; 1980 Oct; 20(10):40-2. PubMed ID: 6160280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lidocaine: antiarrhythmic panacea or cardiac cosmetic agent.
    Lown B
    JAMA; 1981 Nov; 246(21):2482-3. PubMed ID: 7029017
    [No Abstract]   [Full Text] [Related]  

  • 40. Göteborg Metoprolol Trial: effects on arrhythmias.
    Herlitz J; Edvardsson N; Holmberg S; Rydén L; Waagstein F; Waldenström A; Swedberg K; Hjalmarson A
    Am J Cardiol; 1984 Jun; 53(13):27D-31D. PubMed ID: 6731325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.